Michael Kring

High Tech Corporate Services GmbH provides business development and management support services. The firm specializes in the establishment, structuring, and management of administrative and financial divisions of start-up and existing companies. Its service areas encompass administrative and project management, corporate finance, corporate planning and controlling, and human resources. It also provides support during financing rounds, with focus on technology segments of various industries and services. The company was founded by Michael Kring in September 2005 and is headquartered in Munich, Germany.

UniCredit Bank AG provides banking services. It offers banking and financial products to corporate as well as public and private sector clients. The company operates through three segments: Commercial Banking, Corporate & Investment Banking and Other/Consolidation. The Commercial Banking segment offers consumer loans, mortgage loans, savings-and-loan and insurance products and banking services for retail customers. The corporate & Investment Banking segment operates through three divisions HVB, UniCredit Bank Austria AG and UniCredit spa. The other/consolidation segment encompasses the chief operating office business unit, activities of the group corporate center business unit and consolidation effects. The company was founded on July 1, 1869 and is headquartered in Munich, Germany.

Nexigen GmbH identifies and develops peptide based therapeutics for cancer. It focuses on the development of pathways to create transformative cancer therapies. The firm's technologies give access to drug targets which pose significant challenges to conventional discovery approaches. The company was founded by Annette Friebe, Burckhard Heil, and Claudia Carl in 2007 and is headquartered in Cologne, Germany.

BioM AG Munich BioTech Development (BMBD) is a venture capital firm specialized in the life sciences sector. Located in Martinsried on the outskirts of Munich, BMBD was established in 2002 to manage the investment portfolio of BioM AG, a regional technology transfer and venture capital services company. BioM was created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition, and provides business support services to Munich-based biotechnology companies, focusing on start-ups. BMBD manages the BioM Venture Capital fund. Their clients include regional banks, German and European private equity firms and private individuals. The firm operates in partnership with public entities, in particular the German Federal Ministry of Education and Research (BMBF) and HighTech Gründerfonds (HTGF), a partnership between the Government of Germany, the KfW banking group and leading technology corporations.

Cenix BioScience is a contract research organization specialized in combining advanced applications of RNAi with high content phenotypic analyses to enhance and accelerate the discovery and pre-clinical development of novel therapeutics. Cenix has built up a solid track record, successfully advancing therapeutic programs for numerous major industry and academic partners by addressing the specific needs of each through fully-customized, cutting-edge research offerings covering a wide range of disease fields. The well-established core capabilities in high throughput RNAi and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by microRNA-focused experimentation and in vivo applications of synthetic siRNAs. As such, Cenix is a mature and fully-proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of expertise second to none world wide

mvolution GmbH provides integrated mobile solutions for the travel industry. It offers a cross platform, applications for travelers and travel suppliers, and advice and application development services. The company was founded by Stefan Wagner in 2005 and is headquartered in Jena, Germany.

SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany.